Antisense inhibition of P-glycoprotein expression using peptide–oligonucleotide conjugates
- 17 May 2000
- journal article
- research article
- Published by Elsevier BV in Biochemical Pharmacology
- Vol. 60 (1), 83-90
- https://doi.org/10.1016/s0006-2952(00)00310-5
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Transduction of full-length TAT fusion proteins into mammalian cells: TAT-p27Kip1 induces cell migrationNature Medicine, 1998
- Cell penetrating PNA constructs regulate galanin receptor levels and modify pain transmission in vivoNature Biotechnology, 1998
- An Overview of Progress in Antisense TherapeuticsAntisense and Nucleic Acid Drug Development, 1998
- Design of Carrier Peptide-Oligonucleotide Conjugates with Rapid Membrane Translocation and Nuclear Localization PropertiesBiochemical and Biophysical Research Communications, 1998
- Antisense oligonucleotides: towards clinical trialsTrends in Biotechnology, 1996
- Cell Internalization of the Third Helix of the Antennapedia Homeodomain Is Receptor-independentJournal of Biological Chemistry, 1996
- Is p-glycoprotein a potential target for reversing clinical drug resistance?Current Opinion in Oncology, 1994
- Gene inhibition using antisense oligodeoxynucleotidesNature, 1994
- Antisense Oligonucleotides as Therapeutic Agents—Is the Bullet Really Magical?Science, 1993
- Modulation of P-Glycoprotein-Mediated Multidrug Resistance by Monoclonal Antibodies, Immunotoxins or Antisense Oligodeoxynucleotides in Kidney Carcinoma and Normal Kidney CellsOncology, 1993